CD4 and neoplasm: Accumulating studies (Jiang et al., 2021; Zhou et al., 2021) have found that tumor-infiltrating immune cells, including B cells, CD4+/CD8+ T cells, macrophages, neutrophils and dendritic cells, affect the efficacy of chemotherapy and immunotherapy and thus affect the prognosis of patients.